These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26235215)

  • 1. The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex.
    Ma G; Wu Q; Wu X; Arnesano F; Natile G; Sletten E; Liu Y
    J Inorg Biochem; 2015 Dec; 153():239-246. PubMed ID: 26235215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1.
    Crider SE; Holbrook RJ; Franz KJ
    Metallomics; 2010 Jan; 2(1):74-83. PubMed ID: 21072377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum transfer from hCTR1 to Atox1 is dependent on the type of platinum complex.
    Wu X; Yuan S; Wang E; Tong Y; Ma G; Wei K; Liu Y
    Metallomics; 2017 May; 9(5):546-555. PubMed ID: 28383086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1.
    Wu Z; Liu Q; Liang X; Yang X; Wang N; Wang X; Sun H; Lu Y; Guo Z
    J Biol Inorg Chem; 2009 Nov; 14(8):1313-23. PubMed ID: 19669174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between platinum complexes and the C-terminal motif of human copper transporter 1.
    Wang E; Xi Z; Li Y; Li L; Zhao L; Ma G; Liu Y
    Inorg Chem; 2013 May; 52(10):6153-9. PubMed ID: 23642142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters.
    Guo Y; Smith K; Petris MJ
    J Biol Chem; 2004 Nov; 279(45):46393-9. PubMed ID: 15326162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the binding behavior of oxaliplatin, cisplatin and analogues to 5'-GMP in the presence of sulfur-containing molecules by means of capillary electrophoresis and electrospray mass spectrometry.
    Küng A; Strickmann DB; Galanski MS; Keppler BK
    J Inorg Biochem; 2001 Oct; 86(4):691-8. PubMed ID: 11583787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
    Lovejoy KS; Todd RC; Zhang S; McCormick MS; D'Aquino JA; Reardon JT; Sancar A; Giacomini KM; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8902-7. PubMed ID: 18579768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1).
    Du X; Wang X; Li H; Sun H
    Metallomics; 2012 Jul; 4(7):679-85. PubMed ID: 22552365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thioethers on DNA platination by trans-platinum complexes.
    Li C; Huang R; Ding Y; Sletten E; Arnesano F; Losacco M; Natile G; Liu Y
    Inorg Chem; 2011 Sep; 50(17):8168-76. PubMed ID: 21812429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Determinants of Cisplatin and Transplatin Binding to the Met-Rich Motif of Ctr1: A Computational Spectroscopy Approach.
    Nguyen TH; Arnesano F; Scintilla S; Rossetti G; Ippoliti E; Carloni P; Natile G
    J Chem Theory Comput; 2012 Aug; 8(8):2912-20. PubMed ID: 26592130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain.
    Ferri N; Facchetti G; Pellegrino S; Ricci C; Curigliano G; Pini E; Rimoldi I
    Bioorg Med Chem; 2015 May; 23(10):2538-47. PubMed ID: 25865132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin mediates selective downstream hydrolytic cleavage of Met-(Gly)(n)-His segments (n=1,2) in methionine- and histidine-containing peptides: the role of ammine loss trans to the initial Pt-S(Met) anchor in facilitating amide hydrolysis.
    Hohage O; Sheldrick WS
    J Inorg Biochem; 2006 Sep; 100(9):1506-13. PubMed ID: 16806482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA.
    Malina J; Natile G; Brabec V
    Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
    Howell SB; Safaei R; Larson CA; Sailor MJ
    Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes.
    Xi Z; Guo W; Tian C; Wang F; Liu Y
    Metallomics; 2014 Mar; 6(3):491-7. PubMed ID: 24469739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of reaction of L-methionine with carboplatin and oxaliplatin in different media: a comparison with cisplatin.
    Heudi O; Mercier-Jobard S; Cailleux A; Allain P
    Biopharm Drug Dispos; 1999 Mar; 20(2):107-16. PubMed ID: 10206326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in binding kinetics, bond strength and adduct formation between Pt-based drugs and S- or N-donor groups: A comparative study using mass spectrometry techniques.
    Artiaga G; Iglesias-Jiménez A; Moreno-Gordaliza E; Mena ML; Gómez-Gómez MM
    Eur J Pharm Sci; 2019 Apr; 132():96-105. PubMed ID: 30844436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
    Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT
    Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
    Park GY; Wilson JJ; Song Y; Lippard SJ
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11987-92. PubMed ID: 22773807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.